Netherlands Cancer Insitute
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1913-10-10
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nki.nl
Clinical Trials
232
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (197 trials with phase data)• Click on a phase to view related trials
Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
- Conditions
- Non Hodgkin LymphomaDLBCLCardiovascular DiseasesCardiomyopathiesCardiotoxicityMetabolic SyndromeQuality of LifeLate EffectHeart Failure
- First Posted Date
- 2025-06-27
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 217
- Registration Number
- NCT07041827
- Locations
- 🇳🇱
Netherlands Cancer Institute, Amsterdam, North Holland, Netherlands
Functional Liver After SBRT
- Conditions
- Liver Metastases
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT07033364
TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06931769
- Locations
- 🇳🇱
The Netherlands Cancer Institute, Amsterdam, Netherlands
Bevacizumab Versus Corticosteroids As First-line Treatment in Patients with Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases
- Conditions
- Radiation NecrosisHigh Grade Glioma (III or IV)Brain MetastasasesRadiation ToxicityRadiation EffectRadiation InjuryRadiation Injuries
- Interventions
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 408
- Registration Number
- NCT06888817
- Locations
- 🇳🇱
Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands
🇳🇱Amsterdam University Medical Centers, location VUmc and AMC, Amsterdam, Netherlands
🇳🇱Leiden University Medical Center, Leiden, Netherlands
PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
- Conditions
- Erectile Dysfunction Following Radical Prostatectomy
- Interventions
- Device: Erectile vacuum device
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 198
- Registration Number
- NCT06875258
- Locations
- 🇳🇱
Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands
🇳🇱Antoni van Leeuwenhoek hospital, Netherlands Cancer Institute, Amsterdam, Noord-holland, Netherlands
🇳🇱Maasstad ziekenhuis, Rotterdam, Zuid-Holland, Netherlands
- Prev
- 1
- 2
- 3
- 4
- 5
- 44
- Next